Charles Ellis
Last active: 9/24/2018

  1. Metabolic Effects of Diet and Exercise in Patients with Moderate to Severe CKD: A Randomized Clinical Trial. Ikizler TA, Robinson-Cohen C, Ellis C, Headley SAE, Tuttle K, Wood RJ, Evans EE, Milch CM, Moody KA, Germain M, Limkunakul C, Bian A, Stewart TG, Himmelfarb J (2018) J Am Soc Nephrol 29(1): 250-259
    › Primary publication · 29038285 (PubMed) · PMC5748901 (PubMed Central)
  2. Insulin resistance is a significant determinant of sarcopenia in advanced kidney disease. Deger SM, Hewlett JR, Gamboa J, Ellis CD, Hung AM, Siew ED, Mamnungu C, Sha F, Bian A, Stewart TG, Abumrad NN, Ikizler TA (2018) Am J Physiol Endocrinol Metab 315(6): E1108-E1120
    › Primary publication · 29894202 (PubMed) · PMC6336962 (PubMed Central)
  3. Tissue sodium accumulation and peripheral insulin sensitivity in maintenance hemodialysis patients. Deger SM, Wang P, Fissell R, Ellis CD, Booker C, Sha F, Morse JL, Stewart TG, Gore JC, Siew ED, Titze J, Ikizler TA (2017) J Cachexia Sarcopenia Muscle 8(3): 500-507
    › Primary publication · 28150400 (PubMed) · PMC5476848 (PubMed Central)
  4. Systemic inflammation is associated with exaggerated skeletal muscle protein catabolism in maintenance hemodialysis patients. Deger SM, Hung AM, Gamboa JL, Siew ED, Ellis CD, Booker C, Sha F, Li H, Bian A, Stewart TG, Zent R, Mitch WE, Abumrad NN, Ikizler TA (2017) JCI Insight 2(22)
    › Primary publication · 29202452 (PubMed) · PMC5752392 (PubMed Central)
  5. Measurement and Correlation of Indices of Insulin Resistance in Patients on Peritoneal Dialysis. King-Morris KR, Deger SM, Hung AM, Egbert PA, Ellis CD, Graves A, Shintani A, Ikizler TA (2016) Perit Dial Int 36(4): 433-41
    › Primary publication · 26526047 (PubMed) · PMC4853288 (PubMed Central)
  6. Leucine disposal rate for assessment of amino acid metabolism in maintenance hemodialysis patients. Denny GB, Deger SM, Chen G, Bian A, Sha F, Booker C, Kesler JT, David S, Ellis CD, Ikizler TA (2016) BMC Nutr
    › Primary publication · 27413537 (PubMed) · PMC4939826 (PubMed Central)
  7. High Dose Omega-3 Fatty Acid Administration and Skeletal Muscle Protein Turnover in Maintenance Hemodialysis Patients. Deger SM, Hung AM, Ellis CD, Booker C, Bian A, Chen G, Abumrad NN, Ikizler TA (2016) Clin J Am Soc Nephrol 11(7): 1227-35
    › Primary publication · 27281699 (PubMed) · PMC4934832 (PubMed Central)
  8. Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients. Hung AM, Booker C, Ellis CD, Siew ED, Graves AJ, Shintani A, Abumrad NN, Himmelfarb J, Ikizler TA (2015) Nephrol Dial Transplant 30(2): 266-74
    › Primary publication · 25204316 (PubMed) · PMC4309191 (PubMed Central)
  9. Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients. Rivara MB, Ikizler TA, Ellis CD, Mehrotra R, Himmelfarb J (2015) BMC Nephrol : 79
    › Primary publication · 26045064 (PubMed) · PMC4455324 (PubMed Central)
  10. Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial. Himmelfarb J, Ikizler TA, Ellis C, Wu P, Shintani A, Dalal S, Kaplan M, Chonchol M, Hakim RM (2014) J Am Soc Nephrol 25(3): 623-33
    › Primary publication · 24371300 (PubMed) · PMC3935590 (PubMed Central)